| |
Latest 10 SEC filings (by transaction date) for OCGN within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Apr 17/24 | Apr 16/24 | Qamar Huma | Direct Ownership | Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 308,465 | |
Mar 20/24 | Mar 20/24 | Qamar Huma | Direct Ownership | Common Stock | Form 3 : Initial Statement of Beneficial Ownership of Securities | ||
Jan 5/24 | Jan 3/24 | Musunuri Shankar | Direct Ownership | Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -180,204 | $0.653 |
Jan 5/24 | Jan 3/24 | Upadhyay Arun | Direct Ownership | Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -41,633 | $0.653 |
Jan 4/24 | Jan 2/24 | Musunuri Shankar | Direct Ownership | Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 492,126 | |
Jan 4/24 | Jan 2/24 | Upadhyay Arun | Direct Ownership | Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 137,795 | |
Sep 19/23 | Sep 16/23 | Upadhyay Arun | Direct Ownership | Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -842 | $0.410 |
Jun 20/23 | Jun 16/23 | Upadhyay Arun | Direct Ownership | Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -917 | $0.510 |
Jun 16/23 | Jun 14/23 | Zhang Junge | Indirect Ownership | Common Stock | P - Open market or private purchase | 200,278 | $0.499 |
Jun 9/23 | Jun 9/23 | Castillo Kirsten | Direct Ownership | Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 112,205 | |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for OCGN within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Apr 17/24 | Apr 16/24 | Qamar Huma | Direct Ownership | Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 308,465 | |
Mar 20/24 | Mar 20/24 | Qamar Huma | Direct Ownership | Common Stock | Form 3 : Initial Statement of Beneficial Ownership of Securities | ||
Jan 5/24 | Jan 3/24 | Musunuri Shankar | Direct Ownership | Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -180,204 | $0.653 |
Jan 5/24 | Jan 3/24 | Upadhyay Arun | Direct Ownership | Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -41,633 | $0.653 |
Jan 4/24 | Jan 2/24 | Musunuri Shankar | Direct Ownership | Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 492,126 | |
Jan 4/24 | Jan 2/24 | Upadhyay Arun | Direct Ownership | Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 137,795 | |
Sep 19/23 | Sep 16/23 | Upadhyay Arun | Direct Ownership | Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -842 | $0.410 |
Jun 20/23 | Jun 16/23 | Upadhyay Arun | Direct Ownership | Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -917 | $0.510 |
Jun 16/23 | Jun 14/23 | Zhang Junge | Indirect Ownership | Common Stock | P - Open market or private purchase | 200,278 | $0.499 |
Jun 9/23 | Jun 9/23 | Castillo Kirsten | Direct Ownership | Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 112,205 | |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Medpace Holdings (OQ:MEDP) |
United Therapeutics (OQ:UTHR) |
Disc Medicine (OQ:IRON) |